title: The human adenovirus 5 L4 promoter is activated by cellular stress response protein p53.
abstract: During adenovirus infection, the emphasis of gene expression switches from early genes to late genes in a highly regulated manner. Two gene products, L4-22K and L4-33K, contribute to this switch by activating the major late transcription unit (MLTU) and regulating the splicing of its transcript. L4-22K and L4-33K expression is driven initially by a recently described L4 promoter (L4P) embedded within the MLTU that is activated by early and intermediate viral factors: E1A, E4 Orf3, and IVa2. Here we show that this promoter is also significantly activated by the cellular stress response regulator, p53. Exogenous expression of p53 activated L4P in reporter assays, while depletion of endogenous p53 inhibited the induction of L4P by viral activators. Chromatin immunoprecipitation studies showed that p53 associates with L4P and that during adenovirus type 5 (Ad5) infection, this association peaks at 12 h postinfection, coinciding with the phase of the infectious cycle when L4P is active, and is then lost as MLP activation commences. p53 activation of L4P is significant during Ad5 infection, since depletion of p53 prior to infection of either immortalized or normal cells led to severely reduced late gene expression. The association of p53 with L4P is transient due to the action of products of L4P activity (L4-22K/33K), which establish a negative feedback loop that ensures the transient activity of L4P at the start of the late phase and contributes to an efficient switch from early- to late-phase virus gene expression.
authors: School of Life Sciences, University of Warwick, Coventry, United Kingdom.
authors: Jordan
authors: J
authors: Wright
authors: Keith N
authors: KN
authors: Leppard
mesh_terms: D000260:Adenoviruses, Human / Q000235:genetics*; D002460:Cell Line; D047369:Chromatin Immunoprecipitation; D015967:Gene Expression Regulation, Viral; D054884:Host-Pathogen Interactions; D006801:Humans; D011401:Promoter Regions, Genetic; D011485:Protein Binding; D015533:Transcriptional Activation; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*
chemical_list: D016159:Tumor Suppressor Protein p53
references: Virology. 2003 Sep 15;314(1):394-402
references: 14517091
references: Virology. 1984 Jul 30;136(2):387-403
references: 6205505
references: J Virol. 2007 Nov;81(22):12450-7
references: 17804492
references: J Virol. 2006 Jul;80(14):6973-81
references: 16809303
references: Proc Natl Acad Sci U S A. 2004 Dec 21;101(51):17831-6
references: 15591107
references: J Gen Virol. 2000 Nov;81(Pt 11):2573-2604
references: 11038369
references: Virology. 1994 Sep;203(2):229-40
references: 8053147
references: Cell. 1980 Dec;22(3):905-16
references: 7460018
references: Virus Res. 2010 Aug;151(2):220-8
references: 20621673
references: Nature. 1992 May 7;357(6373):82-5
references: 1533443
references: J Virol. 2012 Oct;86(19):10474-83
references: 22811519
references: Virology. 1985 Apr 15;142(1):44-58
references: 2932843
references: J Virol. 2007 Feb;81(3):1327-38
references: 17093188
references: Genes Dev. 1993 Apr;7(4):535-45
references: 8384579
references: Nat Med. 1998 Sep;4(9):1068-72
references: 9734403
references: Nature. 1981 Mar 12;290(5802):113-8
references: 7207591
references: J Virol. 2010 Jul;84(14):7096-104
references: 20444889
references: J Virol. 2004 Feb;78(4):1782-91
references: 14747543
references: J Virol. 2009 Dec;83(23):12172-84
references: 19759146
references: Nat Rev Mol Cell Biol. 2007 Apr;8(4):275-83
references: 17380161
references: EMBO J. 1999 Nov 15;18(22):6455-61
references: 10562557
references: Virology. 1990 Aug;177(2):595-605
references: 2142558
references: J Virol. 2006 Mar;80(6):3042-9
references: 16501113
references: Cell. 1978 Jan;13(1):181-8
references: 620421
references: J Biol Chem. 2006 Dec 1;281(48):36510-7
references: 17028184
references: Cell. 1982 Feb;28(2):387-94
references: 6277513
references: J Virol. 2013 Jul;87(13):7688-99
references: 23637408
references: J Virol. 1985 Sep;55(3):533-46
references: 3894685
references: J Virol. 2009 Apr;83(8):3591-603
references: 19211769
references: Nature. 2010 Aug 26;466(7310):1076-81
references: 20740008
references: J Virol. 2011 Sep;85(17):8752-65
references: 21697482
references: Biologicals. 1990 Apr;18(2):143-6
references: 2375860
references: J Virol. 1999 Jul;73(7):5333-44
references: 10364280
references: J Gen Virol. 2003 Feb;84(Pt 2):259-268
references: 12560556
references: J Virol. 2013 May;87(10):6044-6
references: 23487462
references: J Virol. 2004 Jul;78(14):7685-97
references: 15220443
references: Genes Dev. 2001 Dec 1;15(23):3104-17
references: 11731475
references: J Virol. 1999 Mar;73(3):2253-62
references: 9971808
references: J Virol. 2009 Apr;83(7):3049-58
references: 19176628
references: J Virol. 2013 Jun;87(12):6739-47
references: 23552425
references: Oncogene. 2006 Mar 9;25(10):1509-20
references: 16247442
references: Cancer Res. 2000 May 15;60(10):2666-72
references: 10825139
references: J Virol. 1996 Jul;70(7):4805-10
references: 8676512